Prognostic Implications of

18F-FDG 68Ga-FAPI-46 PET/CT overall survival total lesion number

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
23 May 2024
Historique:
received: 31 10 2023
revised: 07 05 2024
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 23 5 2024
Statut: aheadofprint

Résumé

Tumoral fibroblast activation protein expression is associated with proliferation and angiogenesis and can be visualized by PET/CT. We examined the prognostic value of [

Identifiants

DOI: 10.2967/jnumed.123.266981 PMID: 38782454
pubmed: 38782454
pii: jnumed.123.266981
doi: 10.2967/jnumed.123.266981
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Masao Watanabe (M)

Department of Nuclear Medicine, University Clinic Essen, Essen, Germany; d7he4ng@gmail.com.
Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Wolfgang P Fendler (WP)

Department of Nuclear Medicine, University Clinic Essen, Essen, Germany.
Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Hong Grafe (H)

Department of Nuclear Medicine, University Clinic Essen, Essen, Germany.
Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Nader Hirmas (N)

Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Rainer Hamacher (R)

Department of Medical Oncology, West German Cancer Center, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Helena Lanzafame (H)

Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Kim M Pabst (KM)

Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Hubertus Hautzel (H)

Department of Nuclear Medicine, University Clinic Essen, Essen, Germany.

Clemens Aigner (C)

Department of Thoracic Surgery and Thoracic Endoscopy, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Stefan Kasper (S)

Department of Medical Oncology, West German Cancer Center, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Bastian von Tresckow (B)

Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Martin Stuschke (M)

Department of Radiation Therapy, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Sherko Kümmel (S)

Department of Gynecology and Gynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany, and Department of Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Celine Lugnier (C)

Department of Hematology and Oncology with Palliative Care, Ruhr University Bochum, Bochum, Germany.

Boris Hadaschik (B)

Department of Urology, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Viktor Grünwald (V)

Department of Medical Oncology, West German Cancer Center, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.
Department of Urology, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Fadi Zarrad (F)

Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Jens T Siveke (JT)

Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany; and.
Division of Solid Tumor Translational Oncology, German Cancer Center Consortium (DKTK partner site Essen), and German Cancer Research Center, Heidelberg, Germany.

Ken Herrmann (K)

Department of Nuclear Medicine, University Clinic Essen, Essen, Germany.
Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Manuel Weber (M)

Department of Nuclear Medicine, University Clinic Essen, Essen, Germany.
Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Classifications MeSH